Free Trial
NASDAQ:VANI

Vivani Medical Q4 2024 Earnings Report

Vivani Medical logo
$1.05 +0.02 (+1.94%)
As of 04:00 PM Eastern

Vivani Medical EPS Results

Actual EPS
-$0.11
Consensus EPS
-$0.10
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Vivani Medical Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Vivani Medical Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
Monday, March 31, 2025
Conference Call Time
8:30AM ET

Upcoming Earnings

Vivani Medical's Q1 2025 earnings is scheduled for Monday, May 12, 2025, with a conference call scheduled at 4:45 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Remove Ads

Vivani Medical Earnings Headlines

Vivani Medical, Okava expand collaboration to develop OKV-119 for dogs
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Vivani Medical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Vivani Medical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Vivani Medical and other key companies, straight to your email.

About Vivani Medical

Vivani Medical (NASDAQ:VANI), a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

View Vivani Medical Profile

More Earnings Resources from MarketBeat